Asthma
Conditions
Interventions
Standard treatment (asthma treatment other than inhaled drugs that participants have used before participating the study) plus fluticasone furoate 200ug plus vilanterol trifenatate25ug for 12 weeks
S
Sponsors
Showa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Asthma patients visiting the outpatient department of respiratory and allergy medicine at Showa University Hospital 2) Patients whose age at the time of obtaining consent is 20 years or older (regardless of gender) 3) Patients who have no problem with the ellipta inhalation procedure (confirm the inhalation procedure with a practice device before the observation period) 4) Patients with a total ACT score of less than 20 4 weeks after obtaining consent 5) Non-smokers (<10 pack years) 6) Patients who have given written consent to participate in this study
Exclusion criteria
Exclusion criteria: 1) Patients with bronchiectasis, diffuse panbronchiolitis, collagen disease, pulmonary hypertension, sequelae of tuberculosis, interstitial pneumonia, chronic obstructive pulmonary disease 2) Patients who received oral or intravenous steroids with a diagnosis of exacerbation of asthma within 4 weeks before obtaining consent Person 3) Malignant tumor: Patients currently affected or within 1 year after remission 4) Patients diagnosed with eosinophilia syndrome and eosinophilic polyangiitis granulomatosis 5) Patients with a history of parasite infection within the past 6 months 6) Patients who have been or have been receiving biopharmacy within 6 months 7) Patients who have undergone bronchial hyperthermia within the past year 8) Patients diagnosed with angle-closure glaucoma 9) Patients receiving medication for the diagnosis of benign prostatic hyperplasia 10) Patients judged to be ineligible by the judgment of the research doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of change in ACT score from baseline 12 weeks after the start of administration | — |
Countries
Japan
Contacts
Public ContactYOSHITO MIYATA
Showa University School of Medicine Department of Internal Medicine, Division of Respiratory Medicine and Allergology,
Outcome results
None listed